CD37 Antikörper
Kurzübersicht für CD37 Antikörper (ABIN1837524)
Target
Alle CD37 (TSPAN26) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- The antigen CD37 defined by IPO-24 is B lineage restricted and is strongly expressed throughout B cell ontogeny from pre-B cells until the plasmoblasts. CD37 is an extensively glycosylated molecule and usually two and sometimes three N-linked carbohydrate chain are attached to the protein. IPO24 reacts with human B cell lines Daudi, Raji, Namalva, Ramos and CABIL, whereas T cell lines CEM, Molt-4, Jurkat, MT-4, H9 and non-lymphoid cell lines MeWo and A-431 are not labeled. IPO-24 stains B cell follicles and the most strongly labeled elements are mantle zone lymphoid cells. Neutrophils, macrophages, thymocytes and dendritic reticulum cells are negative.
-
Aufreinigung
- Purified
-
Immunogen
-
IPO-24 was generated after immunization of BALB/c mice with spleen cells of a patient with hairy cell leukemia. Mice splenocytes were fused with the P3-X63-Ag8.653 mouse myeloma cell line.
Type of Immunogen: Cells -
Isotyp
- IgG2b
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 4°C.
-
-
- CD37 (TSPAN26) (Tetraspanin 26 (TSPAN26))
-
Andere Bezeichnung
- CD37
-
Hintergrund
-
Name/Gene ID: CD37
Family: Tetraspan
Synonyms: CD37, CD37 antigen, CD37 Molecule, Leukocyte surface antigen CD37, gp52-40, TSPAN26, Leukocyte antigen CD37, Tetraspanin-26, Tspan-26 -
Gen-ID
- 951
-
UniProt
- P11049
-
Pathways
- Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
Target
-